Succinate production in Escherichia coli
Chandresh Thakker1, Irene Martínez, Ka-Yiu San
1Department of Biochemistry and Cell Biology, Rice University, Houston, TX, USA.
Biotechnology Journal
|September 21, 2011
Summary
Engineered Escherichia coli efficiently produces succinate, a key platform chemical from biomass. Optimizing carbon flow and reducing equivalents is crucial for cost-effective, large-scale succinate production.
Area of Science:
- Biotechnology
- Metabolic Engineering
- Industrial Microbiology
Background:
- Succinate is a valuable platform chemical derivable from renewable biomass resources.
- Escherichia coli is a key microbial host for developing succinate production systems.
Purpose of the Study:
- To review the metabolic engineering strategies for enhancing succinate production in Escherichia coli.
- To discuss factors influencing efficient succinate yield and recovery from various feedstocks.
Main Methods:
- Metabolic engineering approaches to balance redox equivalents and carbon flux.
- Strain development through genetic modification and adaptive evolution.
- Application of systems biology and computational modeling for strain optimization.
Main Results:
- Development of aerobic and anaerobic Escherichia coli strains for succinate production from glucose and other carbon sources.
- Successful application of metabolic engineering and systems biology tools to improve production efficiency.
- Identification of key factors for successful scale-up and economic viability.
Conclusions:
- Escherichia coli can be effectively engineered for high-yield succinate production.
- Optimizing metabolic pathways, feedstock utilization, and downstream processing is essential for commercialization.
- Biorefinery-compatible processes are critical for the economic success of bio-based succinate.
Related Concept Videos
01:30Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
01:27Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...